LAVA Therapeutics NV Financing Cash Flow
LAVA Therapeutics NV reported Financing Cash Flow of -$569.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2025-11-06
- LAVA Therapeutics NV net cash provided by (used in) financing activities for the quarter ending 2024-12-31 was -$594.00K.
- LAVA Therapeutics NV net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $1.00K.
- LAVA Therapeutics NV net cash provided by (used in) financing activities for the quarter ending 2024-06-30 was $16.00K.
- LAVA Therapeutics NV net cash provided by (used in) financing activities for the quarter ending 2024-03-31 was $8.00K.
- LAVA Therapeutics NV net cash provided by (used in) financing activities for fiscal 2024 was -$569.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$594.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$593.00K derived: sum of 2 quarters · filed 2025-11-06 | -$577.00K derived: sum of 3 quarters · filed 2025-11-06 | -$569.00K 10-K · filed 2025-03-28 |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $17.00K derived: sum of 2 quarters · filed 2025-11-06 | $25.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $24.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-14 |